Skip to main content
Clinical Trials/ChiCTR2200055626
ChiCTR2200055626Active, not recruitingEarly Phase 1

13N-NH3 PET/CT 显像诊断肺结节的临床研究

国家重点研发计划1 site in 1 countryStarted: July 1, 2020Last updated:
Conditions

Trial Snapshot

Phase
Early Phase 1
Status
Active, not recruiting
Sponsor
Locations
1
Primary Endpoint
标准摄取值

Study Overview

Brief Summary

探讨 13N-NH3 PET/CT 显像对肺结节患者的鉴别诊断价值。

Study Design

Study Type
诊断试验
Primary Purpose
连续入组
Masking
None

Eligibility Criteria

Ages
18 to — (—)
Sex
All

Inclusion Criteria

  • 临床要求行 18F-FDG PET/CT 检查,且检查前 2 周内 CT 提示肺结节;
  • 肺结节 CT 诊断可疑恶性或性质待定;
  • 自愿参加该项前瞻性研究且签署知情同意书;
  • 术前无任何针对肺结节的治疗。

Exclusion Criteria

  • 有淋巴结转移或远处转移。

Outcomes

Primary Outcomes

标准摄取值

标准摄取最大值

标准摄取平均值

标准摄取最小值

敏感性、特异性、准确性、阳性预测值、阴性预测值

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
国家重点研发计划

Study Sites (1)

Loading locations...

Similar Trials